Insights Lab
Latest insights, research and strategies to help support innovators to achieve real outcomes.
Latest Insights
A summary of developments in the world of the R&D Tax Incentive (R&DTI) program from the previous quarter.
An important reminder for Australian businesses with a 31 December year - the deadline for lodging your 2023 R&D Tax Incentive Application is now less than a month away (31 October 2024).
With the Queensland State Government election fast-approaching, it’s important that any Queensland businesses that are considering applying for state government funding understand what impact the election will have on grant programs. We’ve summarised our analysis of the impact that elections can have on the grant funding landscape, with a particular focus on the Queensland State Government election in October.
A summary over the previous quarter of developments in the world of competitive grant funding, including grant funding opportunities and the update to the National Science and Research Priorities.
In May 2024, AusIndustry released an updated version of their software sector guidance for the R&D Tax Incentive (R&DTI). It’s important to be aware of any changes to guidance materials as this provides an insight into how the program will be administered and the key considerations of the regulators.
The Medical Research Future Fund (MRFF) is a major source of health research funding in Australia, providing opportunities for both researchers and companies. The MRFF publishes funding rounds in advance, giving applicants reasonable notice to prepare. We have prepared an overview of upcoming grant opportunities, eligibility, and how Intellect Labs can support your submission.
With the Queensland State Government election fast-approaching, it’s important that any Queensland businesses that are considering applying for state government funding understand what impact the election will have on grant programs. We’ve summarised our analysis of the impact that elections can have on the grant funding landscape, with a particular focus on the Queensland State Government election in October.
The Medical Research Future Fund (MRFF) is a major source of health research funding in Australia, providing opportunities for both researchers and companies. The MRFF publishes funding rounds in advance, giving applicants reasonable notice to prepare. We have prepared an overview of upcoming grant opportunities, eligibility, and how Intellect Labs can support your submission.
Clinical trials have long been viewed favourably under the R&D Tax Incentive Program. To recognise this, the program offers an efficient registration process for trials registered with the Therapeutic Goods Administration, reducing the administrative burden for biotech companies. This streamlined approach, along with support through Advance Overseas Findings (AOF), empowers Australian biotech firms to innovate and lead on the global stage.
The Overseas Finding process is a crucial component of the Research & Development Tax Incentive (RDTI) in Australia, enabling companies to access a tax benefit for overseas activities that relate to an Australian R&D program. This guide explores the Overseas Finding process, the key conditions for eligibility, and recent ATO concerns as outlined in taxpayer alerts. We also highlight a successful case study with a cyber security innovator, Internet 2.0, to illustrate effective strategies for securing an Overseas Finding.
The R&D Tax Incentive remains Australia’s primary program for supporting businesses undertaking R&D activities with an estimated $3.2 billion annual investment. The program uses a $20 million annual turnover threshold to determine a company’s R&D tax rebate, a threshold that has been unchanged since 2011. In our view, it is time to review this arbitrary line in the sand and ensure the R&DTI aligns with other SME policies so that highly innovative medium sized businesses are incentivised to continue their R&D investment as they grow.
The end of the financial year brings with it some important considerations if you’re planning to lodge an FY24 R&D Tax Incentive claim. We’ve summarised some key things you need to be across.
Featured Posts
Featured Grants
A federal government initiative with $150 million of matched funding available for this first round.
Case Studies
Internet 2.0’s case illustrates how a well-prepared Overseas Funding application can lead to significant financial support and increased investor confidence. It underscores the importance of strategic planning and thorough documentation in the R&D tax incentive process.
With the help of the R&D Tax Incentive (‘RDTI’) program, Dataweavers is investing in R&D to deliver innovative solutions for deploying complex enterprise marketing technology and Digital Experience Platforms (DXPs) in the public cloud.
Ridley Corporation is accessing the R&D Tax Incentive (‘RDTI’) to help them drive innovation in Australian agriculture by providing advanced, sustainable animal nutrition solutions that assist farmers to enhance animal health and productivity while reducing environmental impact.
A $5m grant from the Medical Research Future Fund (MRFF) will help Southern RNA combine its new manufacturing capability with the Queensland research community to create an end-to-end mRNA translation ecosystem.
Start-up medical device company Neurode is accessing the Federal Government’s flagship innovation program, the R&D Tax Incentive (‘RDTI’), to improve quality of life for people diagnosed with ADHD.
Great Wrap is on a mission to remove the 150,000 tonnes of plastic stretch wrap sent to Australia’s landfill each year. A $535,000 grant from the Advanced Manufacturing Growth Centre will help them to do just that.
$2.57m from the Federal Government’s flagship manufacturing program will help Cyclowest fast-track production of next generation cancer treatments.